文献速递胸部肿瘤放疗放疗物理与技术

培美曲塞联合甲氧胺增强非小细胞肺癌放疗敏感性

Radiosensitization of non-small-cell lung cancer cells and xenografts by the interactive effects of pemetrexed and methoxyamine.
PubMed 文献 · Radiother Oncol · 2016-11-09

该临床前研究评估甲氧胺能否增强培美曲塞介导的肺腺癌细胞及异种移植瘤的放疗增敏作用。结果显示联合用药使细胞阻滞于G1/S交界、提高剂量增强因子并降低平均灭活剂量,且异种移植瘤的肿瘤生长率和生长延迟均显著改善,提示该联合方案可能改善局部晚期非鳞非小细胞肺癌的疗效。

要点

  • 培美曲塞联合甲氧胺在放疗前给药可增强A549、H1299及H460细胞的放疗敏感性。
  • 联合方案使细胞聚集于G1/S交界,剂量增强因子为1.62±0.19、1.97±0.25和1.67±0.30。
  • 异种移植瘤中加用甲氧胺显著改善肿瘤生长率和生长延迟(p<0.0001),且无小鼠体重下降。

核心结论

  • 在培美曲塞基础上加用甲氧胺联合分次放疗,可能改善局部晚期非鳞非小细胞肺癌患者的疗效。

研究设计与样本

  • 研究采用A549、H1299及部分研究中的H460肺腺癌细胞系,通过流式细胞术检测细胞周期、克隆形成实验评估放疗增敏、中性彗星实验及修复蛋白活化检测DNA修复。
  • 裸鼠异种移植瘤接受药物和/或放疗,用卡尺监测肿瘤生长,通过动物体重评估体内毒性。

主要发现

  • 培美曲塞/甲氧胺暴露24小时(H1299、H460)或48小时(A549)后照射,细胞聚集于放疗敏感的G1/S交界附近。
  • 三种细胞的剂量增强因子分别为1.62±0.19、1.97±0.25和1.67±0.30,平均灭活剂量分别降低32%、30%和46%。
  • SF2和SF4显著降低(p<0.05),放疗增敏与DNA双链断裂快速重接及DNA-PKcs水平升高相关。
  • 在放疗前给予培美曲塞时加用甲氧胺,肿瘤生长率和肿瘤生长延迟均显著改善(p<0.0001),治疗期间无小鼠体重下降。

临床怎么用

  • 对于局部晚期非鳞非小细胞肺癌,可考虑在培美曲塞基础上加用甲氧胺联合分次放疗以增强放疗敏感性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: The anti-folate pemetrexed is a radiosensitizer. In pre-clinical models, pemetrexed is more effective along with the base-excision-repair inhibitor methoxyamine. We tested whether methoxyamine enhances pemetrexed-mediated radiosensitization of lung adenocarcinoma cells and xenografts. MATERIALS AND METHODS: A549 and H1299 cells were evaluated for cell cycle distribution by flow cytometry, radiosensitization by clonogenic assay, and DNA repair by neutral comet assay and repair protein activation. H460 cells were included in some studies. Xenografts in nude mice received drug(s) and/or radiation, and tumor growth was monitored by caliper and in vivo toxicity by animal weight. RESULTS: Exposure to pemetrexed/methoxyamine for 24 (H1299, H460) or 48 (A549)hours before irradiation resulted in accumulation of cells near the radiosensitive G1/S border; dose-enhancement factors of 1.62±0.19, 1.97±0.25, and 1.67±0.30, respectively; reduction of mean inactivation dose by 32%, 30%, and 46%, respectively; and significant reductions of SF2 and SF4 (p<0.05). Radiosensitization was associated with rapid DNA double-strand-break rejoining and increased levels of DNA-PKcs. Both tumor-growth rate and tumor-growth delay were significantly improved by adding methoxyamine to pemetrexed pre-irradiation (p<0.0001); no mice lost weight during treatment. CONCLUSIONS: Addition of methoxyamine to pemetrexed and fractionated radiotherapy may improve outcome for patients with locally advanced non-squamous non-small-cell lung cancer.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Oleinick NL, Biswas T, Patel R, et al. Radiosensitization of non-small-cell lung cancer cells and xenografts by the interactive effects of pemetrexed and methoxyamine. Radiother Oncol. 2016. PMID: 27838149. doi:10.1016/j.radonc.2016.10.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。